Eli Lilly

LLY

Market cap $673B

1,330 hedge funds and large institutions have $64.9B invested in Eli Lilly in 2018 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 434 increasing their positions, 563 reducing their positions, and 119 closing their positions.

New

Increased

Maintained

Reduced

Closed

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

1,330

Holders Change

-40

Holders Change %

-2.92%

% of All Funds

30.53%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-4.35%

% of All Funds

0.5%

New

Increased

434

Reduced

563

Closed

119

Calls

$316M

Puts

$386M

Net Calls

-$69.6M

Net Calls Change

-$58M

Top Buyers

1	Franklin Resources San Mateo, California	+$311M
2	EVM Eaton Vance Management Boston, Massachusetts	+$255M
3	Ameriprise Minneapolis, Minnesota	+$194M
4	Schroder Investment Management Group London, United Kingdom	+$185M
5	Deutsche Bank Frankfurt Am Main Ge, Germany	+$156M

Top Sellers

1	Bank of America Charlotte, North Carolina	-$368M
2	JPMorgan Chase & Co New York	-$245M
3	Bessemer Group Woodbridge, New Jersey	-$242M
4	LCOV London Company of Virginia Richmond, Virginia	-$206M
5	O OrbiMed New York	-$193M